MDT Medtronic plc

NYSE medtronic.com


$ 95.50 $ 0.13 (0.14 %)    

Monday, 13-Oct-2025 19:36:49 EDT
QQQ $ 601.81 $ 12.51 (2.12 %)
DIA $ 460.92 $ 5.81 (1.28 %)
SPY $ 662.71 $ 10.02 (1.53 %)
TLT $ 90.54 $ -0.05 (-0.06 %)
GLD $ 379.71 $ 8.97 (2.43 %)
$ 95.58
$ 95.70
$ 95.01 x 35
$ 96.00 x 50
$ 95.06 - $ 96.41
$ 76.99 - $ 99.37
4,421,096
na
122.6B
$ 0.67
$ 26.31
TBD
na
na ($ 0.03)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-26-2025 07-25-2025 10-Q
2 06-20-2025 04-25-2025 10-K
3 02-25-2025 01-24-2025 10-Q
4 11-26-2024 10-25-2024 10-Q
5 08-27-2024 07-26-2024 10-Q
6 06-20-2024 04-26-2024 10-K
7 02-27-2024 01-26-2024 10-Q
8 11-30-2023 10-27-2023 10-Q
9 08-31-2023 07-28-2023 10-Q
10 06-22-2023 04-28-2023 10-K
11 03-01-2023 01-27-2023 10-Q
12 12-01-2022 10-28-2022 10-Q
13 09-01-2022 07-29-2022 10-Q
14 06-23-2022 04-29-2022 10-K
15 03-03-2022 01-28-2022 10-Q
16 12-02-2021 10-29-2021 10-Q
17 09-02-2021 07-30-2021 10-Q
18 06-25-2021 04-30-2021 10-K
19 03-05-2021 01-29-2021 10-Q
20 12-03-2020 10-30-2020 10-Q
21 09-03-2020 07-31-2020 10-Q
22 06-19-2020 04-24-2020 10-K
23 02-28-2020 01-24-2020 10-Q
24 12-03-2019 10-25-2019 10-Q
25 08-30-2019 07-26-2019 10-Q
26 06-21-2019 04-26-2019 10-K
27 03-01-2019 01-25-2019 10-Q
28 11-29-2018 10-26-2018 10-Q
29 08-31-2018 07-27-2018 10-Q
30 06-22-2018 04-27-2018 10-K
31 03-02-2018 01-26-2018 10-Q
32 12-04-2017 10-27-2017 10-Q
33 09-01-2017 07-28-2017 10-Q
34 06-27-2017 04-28-2017 10-K
35 03-03-2017 01-27-2017 10-Q
36 12-05-2016 10-28-2016 10-Q
37 09-07-2016 07-29-2016 10-Q
38 06-28-2016 04-29-2016 10-K
39 03-09-2016 01-29-2016 10-Q
40 12-09-2015 10-30-2015 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 stifel-maintains-hold-on-medtronic-raises-price-target-to-105

Stifel analyst Rick Wise maintains Medtronic (NYSE:MDT) with a Hold and raises the price target from $90 to $105.

 medtronic-kicks-off-us-study-on-robot-assisted-surgeries-for-women

Medtronic announces U.S. clinical study for Hugo robotic-assisted surgery system in gynecological procedures.

 medtronic-launches-us-study-of-new-robotic-surgery-system-for-gynecology-hugo-robot-begins-first-us-hysterectomy-surgeries-in-new-clinical-trial

Medtronic plc (NYSE:MDT) today announced the start of the Embrace Gynecology investigational device exemption (IDE) U.S. clinic...

 citigroup-maintains-buy-on-medtronic-raises-price-target-to-112

Citigroup analyst Joanne Wuensch maintains Medtronic (NYSE:MDT) with a Buy and raises the price target from $101 to $112.

 trump-administration-review-targets-medical-supply-chain-vulnerabilities

The U.S. Commerce Department, under the Trump administration, has launched a national security review of medical imports—includ...

 medtronics-new-implant-could-transform-bladder-control-treatment

Medtronic's Altaviva wins FDA approval as a minimally invasive implant for urge urinary incontinence, offering long-lasting...

 medtronic-receives-fda-approval-for-its-altaviva-device-designed-to-treat-urge-urinary-incontinence

 Medtronic plc (NYSE:MDT), a global leader in healthcare technology, announced today that it has received U.S. Food and Drug Ad...

 medtronic-launches-pivotal-study-to-explore-personalized-cardiac-pacing-as-novel-treatment-for-hfpef-patients

Study to evaluate whether a new approach to pacing the heart can improve the lives of patients with heart failure with preserve...

 medtronics-hugo-robotic-system-achieves-100-success-rate-in-hernia-repair-trial

Medtronic's Hugo robotic-assisted surgery system showed strong safety and effectiveness in a U.S. hernia repair study, meet...

 medtronics-hugo-robotic-system-meets-key-endpoints-in-us-ide-clinical-study-for-robotic-assisted-hernia-repair

First-ever investigational device exemption clinical study for robotic-assisted hernia repair in the U.S. presented at the Amer...

 medtronic-secures-fda-clearance-for-smartguard-algorithm-integration-with-abbotts-instinct-sensor-and-approval-of-minimed-780g-for-type-2-diabetes

Medtronic plc (NYSE:MDT), a global leader in healthcare technology, today announced two U.S. Food and Drug Administration (FDA)...

 why-medtronic-has-been-stuck-for-over-1100-days-and-what-lies-ahead

Medtronic has been stuck in a range for 1,100+ days, with weak triads in its Adhishthana cycle keeping the stock in slump until...

 eu-rushes-to-scrap-tariffs-on-us-goods-to-unlock-lower-american-auto-duties-these-exporters-stand-to-gain-big

EU set to scrap tariffs on U.S. goods in a key auto trade deal. See which American industrial and energy stocks are poised for ...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION